{"id":48734,"date":"2026-11-19T07:49:00","date_gmt":"2026-11-19T07:49:00","guid":{"rendered":"https:\/\/ogkologos.com\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/"},"modified":"2026-11-19T07:49:00","modified_gmt":"2026-11-19T07:49:00","slug":"fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/","title":{"rendered":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer"},"content":{"rendered":"<p>\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1.<\/p>\n<p>\u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd.<\/p>\n<p>\u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd.<\/p>\n<p><a href=\"https:\/\/www.esmo.org\/insights-by-esmo\/all-news\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\">\u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1. \u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd. \u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd. \u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO<\/p>","protected":false},"author":2,"featured_media":48712,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[5137],"tags":[5148],"class_list":["post-48734","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-world-news","tag-5148"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1. \u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd. \u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd. \u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Ogkologos\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Ogkologos.com - \u03a0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03ba\u03b1\u03c1\u03ba\u03af\u03bd\u03bf, \u03c4\u03b9\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b5\u03c2, \u03c4\u03b7\u03bd \u03c5\u03c0\u03bf\u03c3\u03c4\u03ae\u03c1\u03b9\u03be\u03b7 \u03ba\u03b1\u03b9 \u03c4\u03b9\u03c2 \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03b9\u03c2 \u03c3\u03c4\u03b7\u03bd \u03bf\u03b3\u03ba\u03bf\u03bb\u03bf\u03b3\u03af\u03b1.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com\" \/>\n\t\t<meta property=\"og:description\" content=\"\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1. \u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd. \u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd. \u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-11-19T07:49:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-19T07:49:00+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com\" \/>\n\t\t<meta name=\"twitter:description\" content=\"\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1. \u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd. \u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd. \u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#blogposting\",\"name\":\"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com\",\"headline\":\"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer\",\"author\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/author\\\/ogkologos\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ogkologos.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/ogk-news-07-viotrapeza.webp\",\"width\":1200,\"height\":675},\"datePublished\":\"2026-11-19T07:49:00+00:00\",\"dateModified\":\"2026-11-19T07:49:00+00:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#webpage\"},\"articleSection\":\"World News, \\u039a\\u03b1\\u03c1\\u03ba\\u03af\\u03bd\\u03bf\\u03c2 \\u03bc\\u03b1\\u03c3\\u03c4\\u03bf\\u03cd\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/category\\\/world-news\\\/#listItem\",\"name\":\"World News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/category\\\/world-news\\\/#listItem\",\"position\":2,\"name\":\"World News\",\"item\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/category\\\/world-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#listItem\",\"name\":\"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#listItem\",\"position\":3,\"name\":\"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/category\\\/world-news\\\/#listItem\",\"name\":\"World News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/#organization\",\"name\":\"Ogkologos.com\",\"description\":\"\\u03a0\\u03bb\\u03b7\\u03c1\\u03bf\\u03c6\\u03bf\\u03c1\\u03af\\u03b5\\u03c2 \\u03b3\\u03b9\\u03b1 \\u03c4\\u03bf\\u03bd \\u03ba\\u03b1\\u03c1\\u03ba\\u03af\\u03bd\\u03bf, \\u03c4\\u03b9\\u03c2 \\u03b8\\u03b5\\u03c1\\u03b1\\u03c0\\u03b5\\u03af\\u03b5\\u03c2, \\u03c4\\u03b7\\u03bd \\u03c5\\u03c0\\u03bf\\u03c3\\u03c4\\u03ae\\u03c1\\u03b9\\u03be\\u03b7 \\u03ba\\u03b1\\u03b9 \\u03c4\\u03b9\\u03c2 \\u03b5\\u03be\\u03b5\\u03bb\\u03af\\u03be\\u03b5\\u03b9\\u03c2 \\u03c3\\u03c4\\u03b7\\u03bd \\u03bf\\u03b3\\u03ba\\u03bf\\u03bb\\u03bf\\u03b3\\u03af\\u03b1.\",\"url\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/author\\\/ogkologos\\\/#author\",\"url\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/author\\\/ogkologos\\\/\",\"name\":\"Ogkologos\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c88a3e4945d8cdfd8855af0ff0f73bf1e3ff152fbcc8cdf60a34c10158b80b08?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Ogkologos\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#webpage\",\"url\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/\",\"name\":\"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com\",\"description\":\"\\u03a3\\u03c4\\u03b9\\u03c2 19\\\/11\\\/2026 \\u03bf \\u03c6\\u03bf\\u03c1\\u03ad\\u03b1\\u03c2 ESMO \\u03b4\\u03b7\\u03bc\\u03bf\\u03c3\\u03af\\u03b5\\u03c5\\u03c3\\u03b5 \\u03b5\\u03bd\\u03b7\\u03bc\\u03ad\\u03c1\\u03c9\\u03c3\\u03b7 \\u03c3\\u03c4\\u03b7\\u03bd \\u03b5\\u03bd\\u03cc\\u03c4\\u03b7\\u03c4\\u03b1 \\u03c1\\u03c5\\u03b8\\u03bc\\u03b9\\u03c3\\u03c4\\u03b9\\u03ba\\u03ce\\u03bd \\u03b5\\u03be\\u03b5\\u03bb\\u03af\\u03be\\u03b5\\u03c9\\u03bd \\u03b3\\u03b9\\u03b1 \\u03c6\\u03ac\\u03c1\\u03bc\\u03b1\\u03ba\\u03b1. \\u0397 \\u03c1\\u03c5\\u03b8\\u03bc\\u03b9\\u03c3\\u03c4\\u03b9\\u03ba\\u03ae \\u03b5\\u03be\\u03ad\\u03bb\\u03b9\\u03be\\u03b7 \\u03c0\\u03bf\\u03c5 \\u03c0\\u03b5\\u03c1\\u03b9\\u03b3\\u03c1\\u03ac\\u03c6\\u03b5\\u03b9 \\u03b7 \\u03c0\\u03b7\\u03b3\\u03ae \\u03b1\\u03c6\\u03bf\\u03c1\\u03ac \\u03c4\\u03bf\\u03bd FDA \\u03c4\\u03c9\\u03bd \\u0397\\u03bd\\u03c9\\u03bc\\u03ad\\u03bd\\u03c9\\u03bd \\u03a0\\u03bf\\u03bb\\u03b9\\u03c4\\u03b5\\u03b9\\u03ce\\u03bd. \\u0398\\u03ad\\u03bc\\u03b1\\u03c4\\u03b1 \\u03c4\\u03b7\\u03c2 \\u03b5\\u03af\\u03b4\\u03b7\\u03c3\\u03b7\\u03c2: \\u039a\\u03b1\\u03c1\\u03ba\\u03af\\u03bd\\u03bf\\u03c2 \\u03bc\\u03b1\\u03c3\\u03c4\\u03bf\\u03cd. \\u03a0\\u03c1\\u03c9\\u03c4\\u03cc\\u03c4\\u03c5\\u03c0\\u03b7 \\u03b4\\u03b7\\u03bc\\u03bf\\u03c3\\u03af\\u03b5\\u03c5\\u03c3\\u03b7 \\u00b7 ESMO\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/author\\\/ogkologos\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/author\\\/ogkologos\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ogkologos.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/ogk-news-07-viotrapeza.webp\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#mainImage\",\"width\":1200,\"height\":675},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\\\/#mainImage\"},\"datePublished\":\"2026-11-19T07:49:00+00:00\",\"dateModified\":\"2026-11-19T07:49:00+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/\",\"name\":\"Ogkologos.com\",\"description\":\"\\u03a0\\u03bb\\u03b7\\u03c1\\u03bf\\u03c6\\u03bf\\u03c1\\u03af\\u03b5\\u03c2 \\u03b3\\u03b9\\u03b1 \\u03c4\\u03bf\\u03bd \\u03ba\\u03b1\\u03c1\\u03ba\\u03af\\u03bd\\u03bf, \\u03c4\\u03b9\\u03c2 \\u03b8\\u03b5\\u03c1\\u03b1\\u03c0\\u03b5\\u03af\\u03b5\\u03c2, \\u03c4\\u03b7\\u03bd \\u03c5\\u03c0\\u03bf\\u03c3\\u03c4\\u03ae\\u03c1\\u03b9\\u03be\\u03b7 \\u03ba\\u03b1\\u03b9 \\u03c4\\u03b9\\u03c2 \\u03b5\\u03be\\u03b5\\u03bb\\u03af\\u03be\\u03b5\\u03b9\\u03c2 \\u03c3\\u03c4\\u03b7\\u03bd \\u03bf\\u03b3\\u03ba\\u03bf\\u03bb\\u03bf\\u03b3\\u03af\\u03b1.\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/ogkologos.com\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com","description":"\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1. \u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd. \u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd. \u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO","canonical_url":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#blogposting","name":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com","headline":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer","author":{"@id":"https:\/\/ogkologos.com\/en\/author\/ogkologos\/#author"},"publisher":{"@id":"https:\/\/ogkologos.com\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/ogkologos.com\/wp-content\/uploads\/2026\/11\/ogk-news-07-viotrapeza.webp","width":1200,"height":675},"datePublished":"2026-11-19T07:49:00+00:00","dateModified":"2026-11-19T07:49:00+00:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#webpage"},"isPartOf":{"@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#webpage"},"articleSection":"World News, \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd"},{"@type":"BreadcrumbList","@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/ogkologos.com\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/ogkologos.com\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/ogkologos.com\/en\/category\/world-news\/#listItem","name":"World News"}},{"@type":"ListItem","@id":"https:\/\/ogkologos.com\/en\/category\/world-news\/#listItem","position":2,"name":"World News","item":"https:\/\/ogkologos.com\/en\/category\/world-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#listItem","name":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer"},"previousItem":{"@type":"ListItem","@id":"https:\/\/ogkologos.com\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#listItem","position":3,"name":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer","previousItem":{"@type":"ListItem","@id":"https:\/\/ogkologos.com\/en\/category\/world-news\/#listItem","name":"World News"}}]},{"@type":"Organization","@id":"https:\/\/ogkologos.com\/en\/#organization","name":"Ogkologos.com","description":"\u03a0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03ba\u03b1\u03c1\u03ba\u03af\u03bd\u03bf, \u03c4\u03b9\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b5\u03c2, \u03c4\u03b7\u03bd \u03c5\u03c0\u03bf\u03c3\u03c4\u03ae\u03c1\u03b9\u03be\u03b7 \u03ba\u03b1\u03b9 \u03c4\u03b9\u03c2 \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03b9\u03c2 \u03c3\u03c4\u03b7\u03bd \u03bf\u03b3\u03ba\u03bf\u03bb\u03bf\u03b3\u03af\u03b1.","url":"https:\/\/ogkologos.com\/en\/"},{"@type":"Person","@id":"https:\/\/ogkologos.com\/en\/author\/ogkologos\/#author","url":"https:\/\/ogkologos.com\/en\/author\/ogkologos\/","name":"Ogkologos","image":{"@type":"ImageObject","@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/c88a3e4945d8cdfd8855af0ff0f73bf1e3ff152fbcc8cdf60a34c10158b80b08?s=96&d=mm&r=g","width":96,"height":96,"caption":"Ogkologos"}},{"@type":"WebPage","@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#webpage","url":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/","name":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com","description":"\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1. \u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd. \u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd. \u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/ogkologos.com\/en\/#website"},"breadcrumb":{"@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#breadcrumblist"},"author":{"@id":"https:\/\/ogkologos.com\/en\/author\/ogkologos\/#author"},"creator":{"@id":"https:\/\/ogkologos.com\/en\/author\/ogkologos\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/ogkologos.com\/wp-content\/uploads\/2026\/11\/ogk-news-07-viotrapeza.webp","@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#mainImage","width":1200,"height":675},"primaryImageOfPage":{"@id":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/#mainImage"},"datePublished":"2026-11-19T07:49:00+00:00","dateModified":"2026-11-19T07:49:00+00:00"},{"@type":"WebSite","@id":"https:\/\/ogkologos.com\/en\/#website","url":"https:\/\/ogkologos.com\/en\/","name":"Ogkologos.com","description":"\u03a0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03ba\u03b1\u03c1\u03ba\u03af\u03bd\u03bf, \u03c4\u03b9\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b5\u03c2, \u03c4\u03b7\u03bd \u03c5\u03c0\u03bf\u03c3\u03c4\u03ae\u03c1\u03b9\u03be\u03b7 \u03ba\u03b1\u03b9 \u03c4\u03b9\u03c2 \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03b9\u03c2 \u03c3\u03c4\u03b7\u03bd \u03bf\u03b3\u03ba\u03bf\u03bb\u03bf\u03b3\u03af\u03b1.","inLanguage":"en-GB","publisher":{"@id":"https:\/\/ogkologos.com\/en\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Ogkologos.com - \u03a0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03ba\u03b1\u03c1\u03ba\u03af\u03bd\u03bf, \u03c4\u03b9\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b5\u03c2, \u03c4\u03b7\u03bd \u03c5\u03c0\u03bf\u03c3\u03c4\u03ae\u03c1\u03b9\u03be\u03b7 \u03ba\u03b1\u03b9 \u03c4\u03b9\u03c2 \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03b9\u03c2 \u03c3\u03c4\u03b7\u03bd \u03bf\u03b3\u03ba\u03bf\u03bb\u03bf\u03b3\u03af\u03b1.","og:type":"article","og:title":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com","og:description":"\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1. \u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd. \u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd. \u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO","og:url":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/","article:published_time":"2026-11-19T07:49:00+00:00","article:modified_time":"2026-11-19T07:49:00+00:00","twitter:card":"summary_large_image","twitter:title":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer - Ogkologos.com","twitter:description":"\u03a3\u03c4\u03b9\u03c2 19\/11\/2026 \u03bf \u03c6\u03bf\u03c1\u03ad\u03b1\u03c2 ESMO \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03be\u03b5\u03bb\u03af\u03be\u03b5\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1. \u0397 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03b7 \u03c0\u03b7\u03b3\u03ae \u03b1\u03c6\u03bf\u03c1\u03ac \u03c4\u03bf\u03bd FDA \u03c4\u03c9\u03bd \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03b9\u03ce\u03bd. \u0398\u03ad\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03af\u03b4\u03b7\u03c3\u03b7\u03c2: \u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2 \u03bc\u03b1\u03c3\u03c4\u03bf\u03cd. \u03a0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u00b7 ESMO"},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/ogkologos.com\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/ogkologos.com\/en\/category\/world-news\/\" title=\"World News\">World News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tFDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/ogkologos.com\/en\/"},{"label":"World News","link":"https:\/\/ogkologos.com\/en\/category\/world-news\/"},{"label":"FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer","link":"https:\/\/ogkologos.com\/en\/fda-approves-giredestrant-in-combination-with-everolimus-for-er-positive-her2-negative-esr1-mutated-locally-advanced-or-metastatic-breast-cancer\/"}],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/48734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=48734"}],"version-history":[{"count":0,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/48734\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media\/48712"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=48734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=48734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=48734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}